Hinge Health Inc. $HNGE Shares Acquired by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. lifted its holdings in Hinge Health Inc. (NYSE:HNGE) by 172.7% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 9,898 shares of the company’s stock after purchasing an additional 6,268 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Hinge Health were worth $382,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Janney Montgomery Scott LLC boosted its holdings in Hinge Health by 3.3% during the first quarter. Janney Montgomery Scott LLC now owns 9,400 shares of the company’s stock worth $362,000 after buying an additional 300 shares in the last quarter. Wells Fargo & Company MN lifted its position in shares of Hinge Health by 160.0% during the 4th quarter. Wells Fargo & Company MN now owns 546 shares of the company’s stock valued at $25,000 after acquiring an additional 336 shares during the last quarter. First Horizon Corp grew its holdings in shares of Hinge Health by 163.9% in the 4th quarter. First Horizon Corp now owns 855 shares of the company’s stock worth $40,000 after acquiring an additional 531 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Hinge Health during the fourth quarter worth $26,000. Finally, Sandler Capital Management lifted its holdings in shares of Hinge Health by 1.4% during the third quarter. Sandler Capital Management now owns 52,728 shares of the company’s stock valued at $2,588,000 after purchasing an additional 728 shares during the last quarter.

Insider Buying and Selling

In related news, major shareholder Insight Holdings Group, Llc sold 181,499 shares of the firm’s stock in a transaction on Thursday, July 9th. The shares were sold at an average price of $90.20, for a total value of $16,371,209.80. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, President James Pursley sold 33,000 shares of the business’s stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $69.31, for a total transaction of $2,287,230.00. Following the transaction, the president directly owned 740,897 shares of the company’s stock, valued at approximately $51,351,571.07. This represents a 4.26% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 3,721,100 shares of company stock worth $288,210,699. 18.92% of the stock is currently owned by insiders.

Hinge Health Price Performance

Shares of HNGE stock opened at $80.00 on Thursday. The firm has a market cap of $6.19 billion, a P/E ratio of 62.50 and a beta of 1.30. The stock’s 50-day moving average is $75.05 and its two-hundred day moving average is $54.43. Hinge Health Inc. has a fifty-two week low of $30.08 and a fifty-two week high of $91.50.

Hinge Health (NYSE:HNGE) last posted its earnings results on Tuesday, August 4th. The company reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.31. Hinge Health had a net margin of 15.15% and a return on equity of 65.44%. The firm had revenue of $212.82 million during the quarter. During the same quarter last year, the firm earned $0.59 earnings per share. Hinge Health’s revenue was up 53.0% compared to the same quarter last year. As a group, research analysts expect that Hinge Health Inc. will post 1.37 EPS for the current year.

Analyst Ratings Changes

Several analysts have issued reports on the company. Zacks Research upgraded Hinge Health from a “hold” rating to a “strong-buy” rating in a report on Wednesday, May 13th. KeyCorp lifted their target price on shares of Hinge Health from $90.00 to $125.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Truist Financial upped their price target on shares of Hinge Health from $79.00 to $85.00 and gave the company a “buy” rating in a research report on Thursday, June 11th. Robert W. Baird lifted their price objective on shares of Hinge Health from $55.00 to $65.00 and gave the stock a “neutral” rating in a research report on Wednesday, June 17th. Finally, Citigroup reissued an “outperform” rating on shares of Hinge Health in a research note on Monday, July 27th. Two analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, Hinge Health has an average rating of “Moderate Buy” and a consensus target price of $98.64.

Key Stories Impacting Hinge Health

Here are the key news stories impacting Hinge Health this week:

• Positive Sentiment: Strong Q2 performance: Hinge Health reported $212.8 million in second-quarter revenue, up 53% year over year. Earnings of $0.59 per share exceeded the $0.28 analyst consensus cited by MarketBeat, while management highlighted stronger member conversion, improved margins and free cash flow that more than tripled from the prior year. Hinge Health quarterly earnings report
• Positive Sentiment: Raised outlook: The company forecast third-quarter revenue of $223 million to $225 million, above the roughly $211 million consensus estimate, and projected 2026 revenue of $856 million to $860 million. The guidance suggests continued momentum in its digital musculoskeletal and migraine-care businesses. Hinge Health 2026 revenue forecast
• Positive Sentiment: Analyst price-target increases: Needham raised its target to $97 from $76 and maintained a Buy rating. Wells Fargo raised its target to $103 from $90 with an Overweight rating, while Citizens JMP lifted its target to $107 from $96 and maintained Market Outperform. The revisions indicate increased confidence in HNGE’s growth prospects.
• Positive Sentiment: Expansion into gastrointestinal care: Hinge Health agreed to acquire Cylinder Health for $105 million in cash. The deal is intended to add a virtual-first gastrointestinal-care program to its existing offerings; management said GI conditions affect about one in four U.S. adults and represent a large healthcare spending opportunity. Broader rollout is planned for 2027. Hinge Health Cylinder Health acquisition
• Neutral Sentiment: Key risks remain: Hinge Health continues to report a negative net margin and negative return on equity, while the cash acquisition introduces integration and execution risks. Its elevated valuation also leaves the stock sensitive to any slowdown in growth or weaker-than-expected adoption of new care programs.

About Hinge Health

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.